Common Barriers Inhibit Pneumococcal Vaccine Uptake Among Older Adults
Drug Topics
JUNE 2, 2025
The most common barriers to vaccination included finances, logistics, availability of information, and hesitancy or refusal.
Sat.May 31, 2025 - Fri.Jun 06, 2025
482 
FDA’s Elsa AI is here, and the industry has questions
PharmaVoice
JUNE 5, 2025
The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
CDC Clarifies That Kids May Receive COVID-19 Vaccine Through Shared Clinical Decision-Making
Pharmacy Times
JUNE 2, 2025
The CDC has updated its COVID-19 vaccine guidance for children and pregnant individuals, sparking a debate among health experts and concerns over insurance coverage.
New report: Post-approval innovation delivers substantial patient benefits
PhRMA
JUNE 2, 2025
Post-approval R&D is the continued investigation by biopharmaceutical companies, often through lengthy clinical trials, to find new uses and improvements for U.S. Food and Drug Administration (FDA)-approved medicines to better meet patient needs. Recently, there has been growing discussion among IP critics aimed at undermining the importance of post-approval R&D.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Mark Cuban Cost Plus Drugs Affiliate Pharmacy Network Aims to Support Independent Pharmacies
Drug Topics
JUNE 3, 2025
A conversation with Erin Albert, MBA, PharmD, JD, DASPL, chief of pharmacy relations, network and privacy, at Cost Plus Drugs.
With ADCs on the rise, drugmakers embrace a new oncology pillar
PharmaVoice
JUNE 6, 2025
Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
When Placebo Plus Standard of Care Clouds the Signal: Unmasking the “Placebo Problem” in Lupus Clinical Trials
Pharmacy Times
JUNE 6, 2025
Juan Ovalles, MD, PhD, discusses how high placebo response rates driven by background therapy complicate lupus drug trials, and outlines evolving strategies in trial design, clinical practice, and pharmacist-led care to ensure investigational biologics are fairly evaluated and appropriately used in systemic lupus erythematosus.
COVID-19 Vaccine Recommendations Spark Confusion and Trust Concerns, Experts Warn
Drug Topics
JUNE 6, 2025
Lauren Angelo, PharmD, MBA, associate dean of academic affairs at Rosalind Franklin University of Medicine and Science, highlights significant concerns about the evolving landscape of COVID-19 vaccine policy.
How leading oncology drugmakers set the stage for future advances
PharmaVoice
JUNE 3, 2025
Drugmakers like J&J and Astellas are looking beyond today’s cancer treatments for the windows of opportunity decades down the road.
STAT+: FDA plans to begin rolling out AI tool agency-wide on Tuesday
STAT
JUNE 2, 2025
The Food and Drug Administration plans to roll out its agency-wide AI tool on Tuesday, weeks ahead of schedule, according to a press release obtained by STAT that provides the most detailed look yet at the technology and how it may be used. Commissioner Marty Makary has hailed the potential of the AI at the FDA, saying it could save employees time and ultimately speed up regulatory reviews.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA Approves mRNA-1283 COVID-19 Vaccine for Adults 65 and Older, Those With Underlying Conditions
Pharmacy Times
JUNE 2, 2025
Amid intensified scrutiny of COVID-19 vaccines at HHS, Modernas mRNA-1283 COVID-19 vaccine was granted FDA approval, for patients 65 years and older and patients aged 12 to 64 years with at least 1 or more underlying risk for severe COVID-19.
Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting
Drug Topics
JUNE 6, 2025
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
3 foods to avoid while taking calcitriol
The Checkup by Singlecare
JUNE 3, 2025
Growing up, there is a strong emphasis on drinking milk to fulfill your vitamin D and calcium needs. But as adults, it’s easy to forget you still need these essential nutrients. While some people eat enough as part of a balanced diet, others develop low calcium levels (calcium deficiency) and may need a prescription supplement like calcitriol , which is sold under the brand name Rocaltrol.
Ingredient up to 13,000 times sweeter than sugar lurks in vapes popular with teens, study shows
STAT
JUNE 2, 2025
Ice cream, lip gloss, and sparkling water are just a few of the products that can contain neotame — an artificial sweetener that’s 7,000-13,000 times sweeter than sugar. Now researchers have found it’s also in many flavored disposable e-cigarettes, which they warn gives them extra appeal to teens and kids. The study , published Monday in JAMA, found neotame in all 11 of the popular disposable vape brands it tested, including Elf Bar, Breeze, and Mr.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Expert Q&A: Pharmacist-Led Strategies to Improve Cholesterol Management
Pharmacy Times
JUNE 3, 2025
Amanda Gronniger, PharmD, CPh, BCCP discusses practical strategies pharmacists can use to improve cholesterol management, from lifestyle counseling to emerging therapies.
Researchers Call for More Data on Impact of Social Determinants of Health for Treatment of Menopause
Drug Topics
JUNE 3, 2025
Social determinants of health have significant impacts on health and quality of life, but little is known about the impact during menopause.
Fierce Healthcare - Untitled Article
Fierce Healthcare
JUNE 2, 2025
HIV and cancer prevention advocates are among the groups worried over cuts to critical programs at HHS under a new fiscal year 2026 budget request.
STAT+: Bristol Myers to partner with BioNTech on experimental cancer drug
STAT
JUNE 2, 2025
Bristol Myers Squibb said Monday it will pay the German firm BioNTech billions of dollars to split rights for an experimental cancer drug called BNT327, which works on both PD-L1, the target of blockbuster drugs Imfinzi and Tecentriq, and VEGF, the target of the blockbuster Avastin. A similar experimental antibody drug, from Summit Therapeutics and the Chinese firm Akeso, has garnered attention because it outperformed Merck’s Keytruda, the best-selling drug in the world, in a study in non
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Sanofi to acquire Blueprint for up to $9.5B
PharmaVoice
JUNE 3, 2025
The pharma giant is betting that Blueprint, whose research revolves around a certain kind of tyrosine kinase, will be a boost to its immunology business.
Esaxerenone Shows Cardiometabolic Benefits for Hypertension, T2D
Drug Topics
JUNE 3, 2025
Esaxerenone is a nonsteroidal mineralocorticoid receptor blocker that is being studied for its effectiveness for diabetes-associated mineralocorticoid receptor-related hypertension.
Darolutamide Approved by FDA for Metastatic Castration-Sensitive Prostate Cancer
Pharmacy Times
JUNE 3, 2025
The FDA has approved darolutamide for patients with metastatic castration-sensitive prostate cancer after positive results in the ARANOTE clinical trial.
STAT+: Kymera reports early-stage success for drug meant to rival Sanofi and Regeneron’s Dupixent
STAT
JUNE 2, 2025
Kymera Therapeutics on Monday reported that an experimental drug designed to rival Sanofi and Regeneron’s blockbuster therapy Dupixent succeeded in a closely watched early-stage trial. The Phase 1 trial, which enrolled 118 healthy volunteers, tested the safety and tolerability of KT-621, a small molecule drug that targets STAT6, a signaling protein that plays a key role in driving immune activation.
Fierce Pharma - Untitled Article
Fierce Pharma
JUNE 6, 2025
How data-driven partnerships and precision engagement are redefining pharma's role in patient care
Weathering the Storm: Pharmacists Exemplify Resilience in the Wake of Natural Disasters
Drug Topics
JUNE 3, 2025
In the aftermath of natural disasters, pharmacists play an essential role in the disaster relief team.
From MGUS to Myeloma: Understanding and Interrupting Disease Progression
Pharmacy Times
JUNE 3, 2025
The 2025 ASCO Annual Meeting discusses the latest advancements in understanding and treating precursor diseases.
STAT+: Pharmalittle: We’re reading about a FDA AI tool, mRNA as a political reject, and more
STAT
JUNE 3, 2025
Top of the morning to you, and a fine one it is. Clear blue skies and pleasant breezes are wafting across the Pharmalot campus, where the official mascots are foraging for their breakfast and rousing the neighbors. This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups of stimulation. Our choice today is banana split, which is fast becoming a trusty favorite.
COVID’s remaining biotech contenders navigate a dwindling market
PharmaVoice
JUNE 2, 2025
With policy and funding evolving, companies are being forced to rethink strategies.
TikTok Videos on IBD Provide Low Quality Information
Drug Topics
JUNE 6, 2025
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Pharmacy Times
JUNE 2, 2025
Frank Qian, MD, MPH, discusses the integration of omega-3 fatty acid therapy alongside statins and PCSK9 inhibitors in cardiovascular risk management, highlighting the distinct mechanisms of benefit and lack of significant drug interactions.
STAT+: Enhertu, used as first option, stalled tumors for more than a year in women with breast cancer, study finds
STAT
JUNE 2, 2025
CHICAGO — The cancer drug Enhertu stalled the growth of tumors by well over a year in a group of women with a type of metastatic but previously untreated breast cancer — study results reported Monday that the drug’s makers AstraZeneca and Daiichi Sankyo believe could change the way the disease is treated for the first time in a decade.
Fierce Healthcare - Untitled Article
Fierce Healthcare
JUNE 2, 2025
The Coalition for Health AI (CHAI) has certified its first partnership for AI model validation, after a 16-month effort to get a nationwide network of AI assurance labs up and running.
GLP-1s Associated With Increased Risk of Neovascular Age-Related Macular Degeneration
Drug Topics
JUNE 6, 2025
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
'Freedom From the Need': A Pharmacist's Journey from Constant Hemophilia B Treatment to Gene Therapy
Pharmacy Times
JUNE 3, 2025
Chip Hailey, a 74-year-old pharmacist with hemophilia B, shares how gene therapy has liberated him from decades of challenging treatment and restored his independence.
Let's personalize your content